On April 2, 2026, Milestone Scientific Inc. filed an 8-K report detailing its entry into an amendment to the Amended and Restated Memorandum of Understanding (MOU) with Innovest S.p.A. This amendment, dated March 31, 2026, revises key definitions within the MOU, specifically those related to 'Qualified Offering' and 'Other Locked-Up Parties'. The changes aim to facilitate a potential offering by the company, which is crucial as it seeks to enhance its capital structure and operational capabilities. The MOU originally established a framework for collaboration between Milestone Scientific and Innovest, particularly concerning BP4 S.r.l., which holds significant consent/blockage rights related to the company's shares. The amendment is expected to streamline the process for Milestone Scientific to raise capital, potentially impacting its liquidity positively. The company currently has 11.31% of its outstanding shares held by BP4, indicating a significant stake that could influence future strategic decisions. This development is viewed as a proactive step by Milestone Scientific to strengthen its financial position and pursue growth opportunities in the market.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.